HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mati Chuamanochan Selected Research

Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)

1/2022Adult-onset immunodeficiency due to anti-interferon-gamma autoantibody-associated Sweet syndrome: A distinctive entity.
11/2021Bullous Sweet syndrome in a patient with acute myeloid leukemia treated with midostaurin: Rapid response to acitretin and colchicine-A case report.
6/2020Efficacy of acitretin in the treatment of reactive neutrophilic dermatoses in adult-onset immunodeficiency due to interferon-gamma autoantibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mati Chuamanochan Research Topics

Disease

3Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
01/2022 - 06/2020
3Chronic Urticaria
01/2022 - 01/2021
2Infections
01/2022 - 12/2013
2Opportunistic Infections (Opportunistic Infection)
01/2022 - 06/2020
2Hypersensitivity (Allergy)
01/2022 - 04/2021
2Urticaria (Hives)
11/2021 - 01/2019
2Skin Diseases (Skin Disease)
06/2020 - 12/2013
1Skin Neoplasms (Skin Cancer)
05/2022
1Lip Neoplasms (Neoplasms, Lip)
05/2022
1Melanoma (Melanoma, Malignant)
05/2022
1Discoid Lupus Erythematosus
04/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021
1Acquired Immunodeficiency Syndrome (AIDS)
10/2021
1Malignant Atrophic Papulosis
04/2021
1Erythema
04/2021
1Cytomegalovirus Infections (Inclusion Disease)
04/2021
1Pruritus (Itching)
01/2021
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2021

Drug/Important Bio-Agent (IBA)

4AcitretinFDA Link
04/2022 - 12/2013
3AutoantibodiesIBA
01/2022 - 06/2020
3Omalizumab (Xolair)FDA Link
01/2022 - 01/2019
3InterferonsIBA
01/2022 - 06/2020
2ligelizumabIBA
01/2022 - 11/2021
2Interferon-gamma (Interferon, gamma)IBA
01/2022 - 06/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 01/2021
2ColchicineFDA LinkGeneric
11/2021 - 12/2013
1Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
05/2022
1Antimalarials (Antimalarial Agents)IBA
04/2022
1beta-LactamsIBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Histamine Antagonists (Antihistamines)IBA
11/2021
1midostaurinIBA
11/2021
1Dental Porcelain (Porcelain)IBA
04/2021
1Pharmaceutical PreparationsIBA
04/2021
1Olopatadine Hydrochloride (Patanol)FDA Link
01/2021
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
01/2021
1Cholinergic Agents (Cholinergics)IBA
01/2019
1DapsoneFDA Link
12/2013
1EtretinateFDA Link
12/2013
1Clofazimine (Lamprene)FDA Link
12/2013
1SteroidsIBA
12/2013